Pathology EMQ template.

Name:

Theme:

 

OPTION LIST

 

A	Ustekinumab	I	Methotrexate
B	Cyclophosphamide	J	Tacrolimus
C	Abatacept	K	Denosumab
D	Azathioprine	L
E	Dexamethasone	M
F	Plasmapheresis	N
G	Anti- thymocyte globulin	O
H	Infliximab	P

 

 

For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.

 

1. Efficacy limited by rebound antibody production

 

 

2. Blocks T cell signalling pathways by inhibiting calcineurin

 

 

3. Therapeutic in rheumatoid arthritis by preventing the activation of T cells via CD28

 

 

4. Treatment with this drug can begin once TPMT gene polymorphism tests are clear

 

 

5. Anti TNF alpha antibody

 

 

 

ANSWERS

1. F

2. J

3. C

4. D

5. H